Stallberg, C.(2017).
Germany ∙ The Albiglutide Controversy: A Paradigm Shift in Pricing Negotiations?.
<em>European Pharmaceutical Law Review, 1</em>(1).
Retrieved from <a href="https://doi.org/10.21552/eplr/2017/1/8">https://doi.org/10.21552/eplr/2017/1/8</a>